Caring for someone with this diagnosis? Eleplan keeps diagnoses, medications, documents and every specialist in one plan.
Start free with EleplanPost 5-alpha-reductase inhibitors treatment syndrome
ORPHA:686468Disease
What it is
A rare neurologic disease characterized by persistent side effects of terminated 5-alpha-reductase inhibitor treatment, including impaired sexual function (low libido, erectile dysfunction, diminished semen volume and force), genital numbness or paresthesia, gynecomastia, depression, brain fog and elevated anxiety. Additional symptoms may include muscular problems (tics, muscle spasms, tremors, involuntary muscle contraction and muscular ache), joint pain, chronic fatigue, migraine, decreased body temperature and dry skin.
Key facts
- Inheritance
- Not applicable
- Classified as
- Disease
ICD-10 codes
ICD-10 has no distinct code for most rare diseases, so many are filed under the nearest available one. A shared code identifies the group, not this disease — the ORPHAcode above is what identifies it.
Related health topics
Reached through the ICD-10 categories this disease is filed under, so these describe the broader group rather than this disease specifically.
Cross-references
Orphadata Science: Free access data from Orphanet. © INSERM 1999. Data version 2026-06-23. Available under CC BY 4.0. This is a reference, not medical advice.
Powered by Eleplan
A rare diagnosis is just the start. Eleplan keeps the whole care plan in one place.
Diagnoses, medications, documents, appointments, and the whole care team — organized and always in sync, so you are not retelling the same story to every new specialist. With Ellie, your AI care assistant, on top of it. Free to start.